Leaflet KETILEPT EP 150mg prolonged-release tablets
Indicated for: schizophrenia; bipolar disorder
Route of administration: oral
Substance: quetiapine (antipsychotic)
ATC: N05AH04 (Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may increase blood sugar.
This medicine may increase the risk of heart rhythm disturbances.
This medicine may increase the risk of seizures.
This medicine may cause drowsiness or reduced alertness.
Quetiapine is an antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and, in some cases, major depressive disorder. It works by regulating the activity of neurotransmitters in the brain, such as dopamine and serotonin.
The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to follow the prescribed dosage and not to discontinue treatment without consulting your doctor.
Side effects may include drowsiness, dizziness, weight gain, dry mouth, or constipation. In rare cases, severe adverse effects such as neuroleptic malignant syndrome or cardiac disorders may occur.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular diseases or diabetes, to ensure the safe use of quetiapine.
General data about KETILEPT EP 150mg
- Substance: quetiapine
- Date of last drug list: 01-07-2015
- Commercial code: W61642001
- Concentration: 150mg
- Pharmaceutical form: prolonged-release tablets
- Quantity: 10
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for quetiapine
Concentrations available for quetiapine
- 100mg
- 150mg
- 200mg
- 25mg
- 25mg/100mg/200mg
- 300mg
- 400mg
- 50mg